ANTIDEPRESSANT-LIKE EFFECTS OF BUSPIRONE MEDIATED BY THE 5-HT1A POSTSYNAPTIC RECEPTORS IN THE LEARNED HELPLESSNESS PARADIGM

被引:44
|
作者
MARTIN, P [1 ]
TISSIER, MH [1 ]
ADRIEN, J [1 ]
PUECH, AJ [1 ]
机构
[1] UNIV PARIS 06,INSERM,U288,F-75634 PARIS 13,FRANCE
关键词
D O I
10.1016/0024-3205(91)90605-B
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The 5-HT1A receptor agonists buspirone and 8-OH-DPAT have strong effects on serotoninergic systems. Mediated by both pre- and post-synaptic 5-HT1A receptors, these pharmacological effects might predict both antidepressant and antianxiety activities. In animal models sensitive to antidepressant drugs, the 5-HT1A agonists administered i.p. have been shown to mimic the behavioral effects of tricyclics. In the present study, the learned helplessness paradigm was used to assess the possible role of pre- or post-synaptic 5-HT1A receptors in this effect. The ability of buspirone compared with 8-OH-DPAT to reduce helpless behavior was investigated after local microinjections (0.1 or 1.0-mu-g in 0.5-mu-l) into the raphe nuclei or into the septum. The results indicate that microinjections of buspirone or 8-OH-DPAT into the raphe nuclei did not reverse helpless behavior; in contrast, microinjections of both 5-HT1A agonists into the septum reverse helpless behavior. These results suggest that antidepressant-like properties of buspirone and 8-OH-DPAT may be mediated, in this test, by the post-synaptic 5-HT1A receptors through functional enhancement of the 5-HT transmission.
引用
收藏
页码:2505 / 2511
页数:7
相关论文
共 50 条
  • [1] ANTIDEPRESSANT-LIKE ACTION OF 8-OH-DPAT, A 5-HT1A AGONIST, IN THE LEARNED HELPLESSNESS PARADIGM - EVIDENCE FOR A POSTSYNAPTIC MECHANISM
    MARTIN, P
    BENINGER, RJ
    HAMON, M
    PUECH, AJ
    BEHAVIOURAL BRAIN RESEARCH, 1990, 38 (02) : 135 - 144
  • [2] ANTIDEPRESSANT-LIKE EFFECT BY POSTSYNAPTIC 5-HT1A RECEPTOR ACTIVATION IN MICE
    MATSUDA, T
    SOMBOONTHUM, P
    SUZUKI, M
    ASANO, S
    BABA, A
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 280 (02) : 235 - 238
  • [3] Antidepressant-like effects of dezocine in mice: involvement of 5-HT1A and κ opioid receptors
    Shang, Li
    Duan, Cunhao
    Chang, Shui
    Chang, Ning
    Jia, Shushan
    BEHAVIOURAL PHARMACOLOGY, 2021, 32 (06): : 472 - 478
  • [4] Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors
    Zanelati, T. V.
    Biojone, C.
    Moreira, F. A.
    Guimaraes, F. S.
    Joca, S. R. L.
    BRITISH JOURNAL OF PHARMACOLOGY, 2010, 159 (01) : 122 - 128
  • [5] MEDIATION OF THE ANTIDEPRESSANT-LIKE EFFECT OF 8-OH-DPAT IN MICE BY POSTSYNAPTIC 5-HT1A RECEPTORS
    LUSCOMBE, GP
    MARTIN, KF
    HUTCHINS, LJ
    GOSDEN, J
    HEAL, DJ
    BRITISH JOURNAL OF PHARMACOLOGY, 1993, 108 (03) : 669 - 677
  • [6] SINGLE ADMINISTRATION OF 5-HT1A AGONISTS DECREASES 5-HT1A PRESYNAPTIC, BUT NOT POSTSYNAPTIC RECEPTOR-MEDIATED RESPONSES - RELATIONSHIP TO ANTIDEPRESSANT-LIKE ACTION
    KENNETT, GA
    MARCOU, M
    DOURISH, CT
    CURZON, G
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 138 (01) : 53 - 60
  • [7] Antidepressant-like activity of Tagetes lucida Cav. is mediated by 5-HT1A and 5-HT2A receptors
    H. Bonilla-Jaime
    G. Guadarrama-Cruz
    F. J. Alarcon-Aguilar
    O. Limón-Morales
    G. Vazquez-Palacios
    Journal of Natural Medicines, 2015, 69 : 463 - 470
  • [8] Antidepressant-like activity of Tagetes lucida Cav. is mediated by 5-HT1A and 5-HT2A receptors
    Bonilla-Jaime, H.
    Guadarrama-Cruz, G.
    Alarcon-Aguilar, F. J.
    Limon-Morales, O.
    Vazquez-Palacios, G.
    JOURNAL OF NATURAL MEDICINES, 2015, 69 (04) : 463 - 470
  • [9] S-adenosyl-l-methionine antidepressant-like effects involve activation of 5-HT1A receptors
    Sales, Amanda J.
    Maciel, Izaque S.
    Crestani, Carlos C.
    Guimara, Francisco S.
    Joca, Samia R. L.
    NEUROCHEMISTRY INTERNATIONAL, 2023, 162
  • [10] Cannabidiol induces antidepressant-like effect in mice:: Possible involvement of 5-HT1A receptors
    Zanelati, T. V.
    Moreir, F. A.
    Joca, S. R. L.
    Guimaraes, F. S.
    BEHAVIOURAL PHARMACOLOGY, 2007, 18 : S17 - S17